Skip to content
10-Q

Quarterly Report

SCIVANTA MEDICAL CORP

0001493152-16-010955

← back to feed
Filed
Jun 20, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2016 · Jun 17, 2016 20.81M sh
Operating Cash Flow Q2 2016 · Apr 30, 2016 −$32.68K
Operating Cash Flow Q2 2016 · Apr 30, 2015 −$49.31K
Cash And Equivalents Q2 2016 · Apr 30, 2016 $38.98K
Cash And Equivalents Q2 2016 · Oct 31, 2015 $21.66K
Cash And Equivalents Q2 2016 · Apr 30, 2015 $26.81K
Cash And Equivalents Q2 2016 · Oct 31, 2014 $26.11K
Stockholders Equity Q2 2016 · Apr 30, 2016 −$335.7K
Stockholders Equity Q2 2016 · Oct 31, 2015 −$1.36M
Current Liabilities Q2 2016 · Apr 30, 2016 $380.11K
Current Liabilities Q2 2016 · Oct 31, 2015 $1.29M
Total Liabilities Q2 2016 · Apr 30, 2016 $380.11K
Total Liabilities Q2 2016 · Oct 31, 2015 $1.39M
Current Assets Q2 2016 · Apr 30, 2016 $44.41K
Current Assets Q2 2016 · Oct 31, 2015 $28.63K
Sga Expense Q2 2016 · Apr 30, 2016 $62.37K
Sga Expense Q2 2016 · Apr 30, 2016 $151.13K
Sga Expense Q2 2016 · Apr 30, 2015 $59.85K
Sga Expense Q2 2016 · Apr 30, 2015 $114.15K
Net Income Q2 2016 · Apr 30, 2016 −$128.93K
Net Income Q2 2016 · Apr 30, 2016 −$131.49K
Net Income Q2 2016 · Apr 30, 2015 −$77.77K
Net Income Q2 2016 · Apr 30, 2015 −$151.58K
Operating Income Q2 2016 · Apr 30, 2016 −$62.37K
Operating Income Q2 2016 · Apr 30, 2016 −$46.13K
Operating Income Q2 2016 · Apr 30, 2015 −$59.85K
Operating Income Q2 2016 · Apr 30, 2015 −$114.15K